KLF5 and prostate carcinoma: In addition, conventional comparative genomic hybridization (CGH) studies indicate that deletion spanning the KLF5 locus could occur in as much as 39% of prostate cancers [6], and our earlier deletion analyses suggest that hemizygous deletion is more common than homozygous deletion in prostate cancer [22,50].